David C. Ishizawar
Expertise in
6
conditions

Dr. David C. Ishizawar

Advanced Heart Failure and Transplant Cardiology | Cardiology
University Of North Carolina At Chapel Hill
101 Manning Dr, 
Chapel Hill, NC 
Accepting New Patients
Offers Telehealth
Expertise in
6
conditions
University Of North Carolina At Chapel Hill
101 Manning Dr, 
Chapel Hill, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Ishizawar is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Chapel Hill, North Carolina. Dr. Ishizawar is highly rated in 6 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Failure, and Heart Failure with Preserved Ejection Fraction (HFpEF). Dr. Ishizawar is currently accepting new patients.

His clinical research consists of co-authoring 10 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Advanced Heart Failure and Transplant Cardiology
Cardiology
Licenses
Internal Medicine in WI
Hospital Affiliations
Unc Health Care Wayne
Johnston Health
Rex Hospital
Unc Hospitals
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
FirstCarolinaCare
  • HMO
  • MEDICARE MAPD
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Network Health
  • HMO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
101 Manning Dr, Chapel Hill, NC 27514

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: February 06, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
Surveillance HeartCare® Outcomes Registry
Surveillance HeartCare® Outcomes Registry
Enrollment Status: Active_not_recruiting
Publish Date: January 21, 2026
Intervention Type: Other
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

10 Total Publications

Successful treatment of pulmonary hypertension following hematopoietic stem cell transplant with a single oral tadalafil: a case report.
Successful treatment of pulmonary hypertension following hematopoietic stem cell transplant with a single oral tadalafil: a case report.
Journal: Pulmonary circulation
Published: January 13, 2021
Similar Doctors
Stuart D. Russell
Expertise in
13
conditions
Dr. Stuart D. Russell
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
13
conditions
Dr. Stuart D. Russell
Advanced Heart Failure and Transplant Cardiology | Cardiology

Duke Health Integrated Practice Inc

2301 Erwin Rd, 
Durham, NC 
 (9.6 miles away)
919-684-8111
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Stuart Russell is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Durham, North Carolina. Dr. Russell is highly rated in 13 conditions, according to our data. His top areas of expertise are Heart Failure, Cardiomyopathy, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Transplant, and Tissue Biopsy. Dr. Russell is currently accepting new patients.

Adam D. Devore
Expertise in
9
conditions
Dr. Adam D. Devore
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
9
conditions
Dr. Adam D. Devore
Advanced Heart Failure and Transplant Cardiology | Cardiology

Duke Health Integrated Practice Inc

2351 Erwin Rd, 
Durham, NC 
 (9.6 miles away)
919-684-8111
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Adam Devore is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Durham, North Carolina. Dr. Devore is highly rated in 9 conditions, according to our data. His top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Edema, Heart Transplant, and Endoscopy. Dr. Devore is currently accepting new patients.

Stephen J. Greene
Expertise in
4
conditions
Dr. Stephen J. Greene
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
4
conditions
Dr. Stephen J. Greene
Advanced Heart Failure and Transplant Cardiology | Cardiology

Duke Health Integrated Practice Inc

2301 Erwin Rd, 
Durham, NC 
 (9.6 miles away)
919-684-8111
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Stephen Greene is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Durham, North Carolina. Dr. Greene is highly rated in 4 conditions, according to our data. His top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Cardiomyopathy, Low Blood Pressure, and Heart Transplant. Dr. Greene is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ishizawar's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile